Arvinas, Inc. (ARVN)
9.60
+0.26
(+2.78%)
USD |
NASDAQ |
Aug 25, 16:00
9.60
0.00 (0.00%)
After-Hours: 19:04
Arvinas Price : 9.60 for Aug. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 9.28 | 9.39 | 9.06 | 9.34 | 500358.0 |
| Aug 21, 2026 | 9.02 | 9.39 | 9.00 | 9.365 | 951752.0 |
| Aug 20, 2026 | 9.55 | 9.63 | 8.97 | 9.025 | 601732.0 |
| Aug 19, 2026 | 9.44 | 9.69 | 9.44 | 9.68 | 494207.0 |
| Aug 18, 2026 | 9.19 | 9.332 | 9.10 | 9.26 | 554727.0 |
| Aug 17, 2026 | 8.91 | 9.26 | 8.894 | 9.20 | 584029.0 |
| Aug 14, 2026 | 8.91 | 8.975 | 8.72 | 8.97 | 461290.0 |
| Aug 13, 2026 | 8.91 | 9.09 | 8.855 | 9.01 | 939144.0 |
| Aug 12, 2026 | 8.99 | 8.99 | 8.71 | 8.87 | 524458.0 |
| Aug 11, 2026 | 8.99 | 9.115 | 8.86 | 8.99 | 572103.0 |
| Aug 10, 2026 | 8.70 | 9.02 | 8.590 | 8.99 | 671770.0 |
| Aug 07, 2026 | 8.81 | 8.98 | 8.64 | 8.75 | 1.218M |
| Aug 06, 2026 | 8.40 | 8.716 | 8.37 | 8.68 | 2.581M |
| Aug 05, 2026 | 8.82 | 8.91 | 8.21 | 8.40 | 1.572M |
| Aug 04, 2026 | 8.33 | 9.65 | 8.33 | 9.00 | 3.033M |
| Aug 03, 2026 | 8.10 | 8.17 | 7.92 | 8.06 | 716844.0 |
| Jul 31, 2026 | 8.24 | 8.24 | 7.895 | 8.03 | 687895.0 |
| Jul 30, 2026 | 8.11 | 8.305 | 8.10 | 8.30 | 550055.0 |
| Jul 29, 2026 | 8.18 | 8.34 | 8.09 | 8.22 | 740473.0 |
| Jul 28, 2026 | 8.255 | 8.32 | 8.015 | 8.20 | 551915.0 |
| Jul 27, 2026 | 8.13 | 8.37 | 8.12 | 8.22 | 475560.0 |
| Jul 24, 2026 | 8.11 | 8.16 | 7.95 | 8.03 | 385667.0 |
| Jul 23, 2026 | 8.10 | 8.31 | 8.04 | 8.12 | 704977.0 |
| Jul 22, 2026 | 8.21 | 8.40 | 8.15 | 8.26 | 642472.0 |
| Jul 21, 2026 | 8.02 | 8.29 | 7.96 | 8.26 | 625544.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cocrystal Pharma, Inc. | 1.135 |
| CNBX Pharmaceuticals, Inc. | 0.0002 |
| GB Sciences, Inc. | 0.0003 |
| Fulcrum Therapeutics, Inc. | 3.855 |
| Definium Therapeutics, Inc. | 44.82 |
Price Related Metrics
| PE Ratio | 59.85 |
| PS Ratio | 2.029 |
| Price to Book Value | 1.115 |
| Earnings Yield | 1.67% |
| Market Cap | 626.88M |
| Normalized PE Ratio | 43.88 |